Seeking Clues to Progyny (PGNY) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Core Viewpoint - Wall Street analysts anticipate Progyny (PGNY) will report quarterly earnings of $0.38 per share, reflecting a year-over-year decline of 9.5%, while revenues are expected to be $303.93 million, an increase of 1.8% from the previous year [1] Group 1: Earnings and Revenue Estimates - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] - Analysts project 'Revenue- Pharmacy benefit services revenue' to be $110.78 million, showing a decrease of 0.2% from the prior-year quarter [4] - 'Revenue- Fertility benefit services revenue' is expected to reach $192.06 million, indicating an increase of 2.4% from the year-ago quarter [4] Group 2: Membership and Market Performance - Analysts predict that the 'Average Members' will reach 6,586, compared to 6,471 reported in the same quarter of the previous year [4] - Progyny shares have decreased by 14.3% in the past month, contrasting with the Zacks S&P 500 composite's decline of 0.3% [5] - With a Zacks Rank 3 (Hold), PGNY is expected to closely follow overall market performance in the near term [5]